The widespread use of naturally occurring alkenylbenzenes as flavoring and fragrance agents has led to a long-standing interest in their toxicity and carcinogenicity. Among them several allyl-and propenylbenzenes have been found to be mutagenic and carcinogenic. It has been shown that the carcinogenicity of several allylbenzenes can be related to the formation of electrophilic sulfuric acid esters following 1'-hydroxylation. Unlike the allylbenzenes, the mechanisms of carcinogenesis of propenylbenzenes such as anethole and asarone are not clear. It has been reported that one of the main metabolic pathways of trans-anethole is the epoxidation of the side chain 1,2-double bond, which was responsible for cytotoxicity but not for genotoxicity. However, we report here that synthetic trans-anethole oxide prepared from trans-anethole and dimethyldioxirane is not only mutagenic for Salmonella tester strains but is also carcinogenic in the induction of hepatomas in B6C3F1 mice and skin papillomas in CD-1 mice. Synthetic transasarone oxide was also carcinogenic in the induction of hepatomas as well as mutagenic for Salmonella strains. Further studies are needed on these side chain oxides of trans-anethole and trans-asarone as possible metabolites in the toxicity, mutagenicity and carcinogenicity of these and other propenylbenzenes.
Introduction
Many naturally occurring alkenylbenzene derivatives, usually relatively simple allyl-or propenylbenzenes with methoxy and/or methylenedioxy ring substituents, have been found as components of many plants or their essential oils (1, 2) and have been used as important natural flavoring and fragrance chemicals. The widespread use of these alkenylbenzenes has led to a long-standing interest in their toxicity and carcinogenicity. Several allylbenzenes show carcinogenicity in experimental animals. Safrole (1-allyl-3,4-methylenedioxybenzene), which is a major constituent of oil of sassafras and a component of certain other essential oils (3) , has induced hepatic tumors in mice and rats (2, (4) (5) (6) . Estragole (1-allyl-4-methoxybenzene), a major constituent of the oils of tarragon (estragon) and sweet basil (2) , also has hepatocarcinogenic activity (2, 5) . Methyleugenol (1-allyl-3,4-dimethoxybenzene) appeared to be as active a carcinogen in the mouse liver as safrole and eastragole (2) . These allylbenzenes are metabolized by rat Abbreviations: DMSO, dimethyl sulfoxide; TPA, tetradecanoylphorbol 13-acetate. and mouse liver microsomes to their 1'-hydroxy derivatives followed by sulfation to produce electrophilic sulfuric acid esters, which are involved in their carcinogenicity (10) (11) (12) .
Carcinogenic activities of naturally occurring propenylbenzene derivatives have also been demonstrated. Asarone (1-propenyl-2,4,5-trimethoxybenzene), a major constituent of oil of Calamus which has been used as a flavoring additive in food, beverages and medicines, has been reported to induce mesenchymal tumors (leimyosarcomas) of the small intestine in rats (13, 14) . It is also a known hepatocarcinogen in male B6C3F1 mice (15) . Isosafrole (1-propenyl-3,4-methylendioxybenzene) induced a low incidence of hepatomas in mice (6, 7) . Anethole (1-propenyl-4-methoxybenzene), which is found in the essential oils of many kinds of plants, including fennel and Chinese star anise, did not seem to be carcinogenic in mice (2, 15) , but was a weak hepatocarcinogen in female CD rats (16) . Unlike the allylbenzenes, the carcinogenic mechanism of propenylbenzenes is not clear.
It has been reported that anethole is metabolized along three pathways, O-demethylation, ω-hydroxylation followed by side chain oxidation and epoxidation of the 1,2-double bond (17) (18) (19) . The cytotoxicity of trans-anethole in rat hepatocytes has been shown to be due to its metabolism to the epoxide (20) (21) (22) . Asarone, the carcinogenic propenylbenzene, may also be metabolized to the epoxide in vivo, since it has similar structure to anethole. Thus these electrophilic epoxides of propenylbenzenes could be involved in their biological effects, including toxicity and carcinogenicity. We have recently synthesized trans-anethole oxide and trans-asarone oxide ( Figure 1) by oxidation with dimethyldioxirane and tested them for mutagenicity and carcinogenicity.
Materials and methods

Chemicals and animals
Tetradecanoylphorbol 13-acetate (TPA) was obtained from ChemSyn Science Laboratory (Lenexa, KS). Trioctanoin was purchased from Pfaltz and Bauer (Waterbury, CT). trans-anethole, trans-asarone, glyceraldehyde, activated (4 Å) molecular sieve, Oxone (monopersulfate compound), 4-(4'-nitrobenzyl)pyridine, acetone, hexane, potassium iodide (KI), starch and dimethyl sulfoxide (DMSO) were from Aldrich Chemical Co. (Milwaukee, WI). The other chemicals were obtained from Sigma Chemical Co. (St Louis, MO).
Male C3H/HeJ and female C57BL/6J mice from the Jackson Laboratory (Bar Harbor, ME) were bred in our laboratory to give B6C3F1 offspring. After weaning, the mice were fed modified AIN-76 purified diet (Teklad Diet Co., Madison, WI). The CD-1 mice from the Charles River Breeding Co. (Wilmington, MA) were fed Wayne Breeder Blox pellets (Allied Mills, Chicago, IL).
Synthesis of trans-anethole oxide and trans-asarone oxide
Dimethyldioxirane solution in acetone was made freshly by an improved conventional method (23) . After the solution was dried with molecular sieves (4 Å, activated powder), it was titrated iodometically with KI and starch. The titrated dimethyldioxirane solution (~0.08 M solution in acetone, 1.2 equiv.) was added to trans-anethole or trans-asarone in dry acetone (1 ml for 1 mmol) at 0°C and the reaction mixture was stirred for 30 min at room temperature. The reaction solution was evaporated under reduced pressure to afford the epoxides. trans-anethole oxide was a colorless oil. The yellow oil of transasarone oxide after vacuum application was dissolved in dry hexane and recrystallized at -20°C for a few days to produce a white solid product (m.p. 37-40°C, corr.). The yields of these oxides were Ͼ95%. The oxides were kept at -80°C in dry nitrogen. In this condition trans-anethole oxide was stable for 1 year and trans-asarone oxide was stable for 1 month. The oxides were used within a month for the experiments.
Ames test
Direct mutagenicity of trans-anethole oxide and trans-asarone oxide were assayed in Salmonella typhimurium strains TA1535, TA100 and TA98 following the original procedures of Maron and Ames (24) as modified by Park et al. (25) . Each oxide was dissolved in 20 µl of acetone and was preincubated with bacteria in a total volume of 0.6 ml potassium phosphate buffer (0.1 M, pH 7.4) for 30 min at 37°C in a shaking water bath. After incubation, 2 ml of top agar were added and the mixture was vortexed, plated and incubated at 37°C for 2 days before the his ϩ revertants were scored.
Induction of hepatic tumors
Male B6C3F1 mice (12 days old) were injected once i.p. with trans-anthole, trans-anethole oxide, trans-asarone or trans-asarone oxide. After weaning, they were fed modified AIN-76 purified diet (Teklad Diet Co.) and given water ad libitum. The mice were killed at 10-11 months and the number of hepatomas Ͼ2 mm in diameter and visible on the surface were counted. For the highest dose group of trans-asarone oxide (0.5 µmol/g body wt), 100 mice were used so that the group size was 33 mice at the end of the experiment. Each of the other groups was composed of 35 mice in the beginning.
Induction of skin papillomas
Groups of 30 female CD-1 mice (6-8 weeks old) were treated on their shaven back with 2.5 µg TPA in 0.1ml acetone. After 24 h, mice were treated with doses of 5 µmol of trans-anethole, trans-anethole oxides, trans-asarone or trans-asarone oxide once weekly for 3 weeks and thereafter twice weekly with topical TPA (2.5 µg in 0.1 ml acetone). The mice were reshaved as necessary and papillomas were enumerated at bi-weekly intervals. The experiment was terminated at 20 weeks.
Stability of trans-anethole oxide and trans-asarone oxide
The half-lives of the alkylating activity of trans-anethole oxide and transasarone oxide were determined by the method of Park et al. (25) . The oxide solution (75 mg in 10 ml acetone) was mixed with 20 ml of 0.1 M phosphate buffer (pH 7.4) and incubated at 37°C. At various times (~0.5-25 min) after incubation at 37°C, an aliquot of 1 ml was transferred to a cap tube which contained 0.3 ml of acetone and 1.7 ml of 3.3% 4-(4'-nitrobenzyl)pyridine in ethylene glycol. Each tube was incubated at 37°C for 20 min, placed in a dry ice/acetone bath for 1 min and 2.0 ml of triethylamine/acetone (1:1 v/v) was added. The absorbance at 560 nm was measured.
Results
Purity of trans-anethole oxide and trans-asarone oxide
The structures of trans-anethole oxide and trans-asarone oxide are shown in Figure 1 . trans-anethole oxide and trans-asarone oxide were found to have very pure NMR spectra with little or no impurity peaks. The yields of oxides from this method were Ͼ95%, which are much better than those of Mohan and Whalen (27) and Greca et al. (39) , whose methods used mchloroperoxybenzoic acid to oxidize anethole or asarone and gave yields of 38 and 52%, respectively. Our trans-anethole oxide had an EIMS spectrum (70 eV (39) , who used α-asarone extracted from Acorus gramineus for synthesis, agreed with ours except that their 1' proton had an upper chemical shift. He also claimed that the oxyranypropane was obtained from the plant, but this is doubtful because his work-up and separation methods included an aqueous environment that would destroy the oxirane structure.
Stability of trans-anethole oxide and trans-asarone oxide
Both of the oxides were stable in acetone or DMSO for 1 h at 0 or 37°C (data not shown). In aqueous environments, however, the amount of these epoxides declined, presumably because of their hydration to diols. The half-life of transanethole oxide was 7.6 min in 0.1 M potassium phosphate buffer (pH 7.4) at 37°C. The presence of 154 mM KCl lowered the half-life to 4.2 min. Trans-asarone oxide showed shorter half-lives; 4.0 min without or 2.4 min with 154 mM KCl.
Mutagenicity for Salmonella typhimurium
Mutagenicity studies of trans-anethole oxide and trans-asarone oxide were carried out as described in Materials and methods. Both of the oxides showed dose-dependent mutagenicity in point mutation models (TA1535 and TA100) and in a frameshift mutation model (TA98). Trans-asarone oxide was more mutagenic than trans-anethole oxide in all strains (Figures 2-4) .
Induction of liver tumor formation in infant B6C3F1 mice
As shown in Table I , a single i.p. injection of trans-anethole and trans-anethole oxide produced slight increases in hepatomas in male B6C3F1 mice, but only the highest dose of trans-anethole oxide was statistically significant (P Ͻ 0.01). Treatment with trans-asarone induced hepatomas up to~90% with both doses (0.25 and 0.5 µmol/g body wt). With the low doses of transasarone oxide (0.125 and 0.25 µmol/g body wt), hepatoma 
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induction was not significantly different from the trioctanoin treatment. However, the dose of 0.5 µmol/g body wt transasarone oxide exhibited detectable carcinogenic activity, with 50% of hepatomas in the surviving animals, in which the average number of hepatomas increased significantly (P Ͻ 0.01).
Induction of skin papilloma in female CD-1 mice
Unlike the parent propenylbenzenes, topical application of ജ10 µmol of the reactive oxides produced sores on mouse skin (data not shown). Therefore, a topical dose of 5 µmol was introduced for this experiment. Topical application of trans-anethole oxide produced a 30% incidence of skin papillomas, in which the average number of papillomas per mouse was significantly different from that of acetone application (P Ͻ 0.01; Table II ). However, treatment with trans-anethole, trans-asarone and trans-asarone oxide did not induce papillomas significantly. Groups of 30 mice were treated topically on their shaven backs with 2.5 µg TPA in 0.1 ml acetone 18-24 h before each topical dose of the test compounds. Three applications of test compounds were given at 1 week intervals followed by twice weekly doses of 2.5 µg TPA in 0.1 ml acetone. The test compounds were dissolved in 0.2 ml acetone. a Treating with 10 or 50 µmol of the oxides produced raw skin sores. However, trans-anethole and trans-asarone did not produce skin sores at these levels. b Significant; P Ͻ 0.05, Fisher's test. c Significant; P Ͻ 0.01, Student's t-test.
Discussion
The culinary use of naturally occurring alkenylbenzene derivatives, which are found in many spicy plants or their essential oils, has led to an interest in their toxicity and carcinogenicity.
In the experiments presented here, the epoxides of propenylbenzenes were positive in the Salmonella mutation assay and induced tumors in mice. These results suggest that epoxidation of the side chain in vivo might be a possible pathway of carcinogenic metabolism of propenylbenzenes. Studies on the metabolism of trans-anethole have revealed three major metabolic pathways: O-demethylation, ω-hydroxylation and side chain epoxidation (17) (18) (19) . By virtue of its high chemical reactivity, epoxidation of the 1,2-double bond of trans-anethole is the pathway of greatest toxicological interest. The preferred route of metabolism in the rat was via epoxidation to diols. At a dose of 1500 mg/kg, 15% of the dose was found as diols in urine (18) . In the mouse, 4.5% of the dose was excreted in the urine as diols. The cytotoxicity of trans-anethole in rat hepatocytes due to its metabolism to epoxide has been reported (20, 21) . Inhibition of cytosolic epoxide hydrolases by 4-fluorochalcone oxide increased the cytotoxicity of anethole in cultured hepatocytes (21) and anethole epoxide itself also showed strong cytotoxicity (22) . In these reports, however, the unscheduled DNA synthesis (UDS) of hepatocytes was not altered by anethole and an epoxide hydrolase inhibitor (21) nor by anethole epoxide itself (22) . These results led Marshall and Caldwell to conclude that anethole oxide was not genotoxic but was cytotoxic (21, 22) .
Indeed, we have found that trans-anethole oxide is more toxic to animals than trans-anethole. Application of 10 µmol trans-anethole oxide to CD-1 mouse skin produced skin sores although no skin sores were found with anethole up to a dose of 50 µmol (Table II) . Intraperitoneal injection of transanethole oxide at a dose of 5 µmol/g body wt killed all 12-day-old male B6C3F1 mice in the group, whereas transanethole did not (data not shown). However, we also found that trans-anethole oxide was mutagenic both in point mutation (Figures 2 and 3 ) and in frameshift mutation (Figure 4 ) models of the Ames test. The oxide produced revertant colonies in a dose-dependent manner. Bacterial cells are probably more resistant to the cytotoxicity of trans-anethole oxide than hepatocytes because the oxide did not show toxicity in Salmonella strains up to a level of 90 µg/plate. It is reported that concentrations Ͼ0.5 mM trans-anethole oxide caused a slightly increased UDS ratio to fall below 1.0 in rat hepatocytes because of cytotoxicity (22) and that the GSH level was reduced to~60% of the control value by 1 mM trans-anethole oxide (22) . Therefore, trans-anethole oxide might be too toxic to hepatocytes to reveal genotoxic effects in the UDS assay. Isosafrole (1-propenyl-3,4-methylenedioxybenzene), which is weakly carcinogenic in mice (6,7), did not induce UDS in hepatocytes (35) . Thus, the UDS assay does not seem to properly extrapolate the mutagenicity or carcinogenicity of propenylbenzenes, although it is a well-known method to assess genetic damage.
The mutagenicity of anethole has been controversial. In Salmonella studies, anethole was negative without metabolic activation. With metabolic activation, however, it was mutagenic (31, 37, 38) in some studies but not in others (29) . Anethole showed positive results with metabolic activation in the mouse lymphoma assay (29, 30) . Other mutagenic assays, including the Escherichia coli point mutation (30) and Saccharomyces cerevisae reversion assays (32), showed negative results. These controversial results, especially with metabolic activation, might arise from the instability of anethole oxide.
As shown in Table I , i.p. injection of trans-anethole did not significantly induce hepatomas in male B6C3F1 mice. However, the highest dose of trans-anethole oxide (0.5 µmol/g body wt) increased the incidence of hepatomas significantly. Topical application to the skin of female CD-1 mice also induced skin papillomas (Table II) . As mentioned earlier, we found that trans-anethole oxide is more toxic to animals than trans-anethole. Its induction of hepatomas and skin papillomas suggests that the epoxidation of anethole in vivo might be responsible for its carcinogenicity as well as toxicity.
Asarone is reported to be mutagenic for Salmonella bacteria (36) and genotoxic to hepatocytes (33) . It induced sister chromatid exchange in both human lymphocytes in vitro and in murine bone marrow cells in vivo (34, 38) . It is also teratogenic to rats (26) as well as carcinogenic in the preweanling mouse model (15) . However, there are few studies on the metabolism of asarone. Since asarone has a similar structure to anethole, they may have the same metabolic fate. Trimethoxycinnamic acid was identified as a metabolite of asarone in cultured rat hepatocytes (33) , suggesting that asarone might have been metabolized through ω-hydroxylation, like anethole. Therefore, it may also be metabolized by the other pathway of anethole, i.e. formation of the epoxide through oxidation of the 1,2-double bond. It has been reported that addition of cimetidine, a CYP2C11 inhibitor, reduced UDS induced by asarone (33) . Furthermore, metabolism of asarone was decreased by cimetidine. It was suggested that the genotoxicity of asarone might be due to an oxidized metabolite, yet it was not made clear what the oxidized structure would be.
As shown in Figures 2-4 , the synthetic trans-asarone oxide showed positive mutagenicity in all strains of Salmonella used in a dose-dependent manner. The effects of trans-asarone oxide were stronger than those of trans-anethole oxide. Trans-asarone oxide, of course, has a shorter half-life, suggesting a higher reactivity than trans-anethole oxide. Unfortunately, induction of skin papillomas by topical application of trans-asarone oxide was not observed (Table II) . However, trans-asarone oxide induced hepatomas in up to 50% of male B6C3F1 mice with a single i.p. injection (Table I ). The lower incidence than with its parent structure, trans-asarone, is probably due to its instability in physiological fluid in vivo. Our results suggest that trans-asarone oxide could be the oxidized metabolite of trans-asarone which is responsible for its mutagenicity and carcinogeniciy as well as toxicity.
As shown in this study, trans-anethole oxide and transasarone oxide are mutagenic to bacterial cells and induce hepatomas and/or skin papillomas. Since it has been reported that one of the main metabolic fates of anethole is formation of the epoxide (17) (18) (19) , anethole oxide may be responsible for the mutagenicity and the weak carcinogenicity of anethole. Likewise, trans-asarone could also be oxidized to the epoxide to be mutagenic and carcinogenic. This proposed mechanism, epoxidation of the 1,2 double bond, might distinguish the propenylbenzenes from the allylbenzenes, whose carcinogenicity is derived from formation of electrophilic sulfuric acid esters following 1'-hydroxylation.
